本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
Ample Transfers plans to broaden digital payment capabilities following in-principle approval from the Monetary Authority of Singapore. SINGAPORE, April 14, 2025 /PRNewswire/ -- Ample Transfers, a Singapore-based provider of remittance and money-changing services established in 1998, has received in-principle approval from the Monetary Authority of Singapore (MAS) to expand its scope of regulated payment services under the Payment Services Act 2019. The approval, part of a licence variation application, allows Ample Transfers to work towards offering four additional regulated services, subject to the fulfilment of conditions set out by MAS: Account issuance service Domestic money transfer service Merchant acquisition service E-money issuance service Ample Transfers is currently licensed to provide cross-border money transfer and money-changing services in Singapore. This milestone positions Ample as one of the few Singapore-based players bridging the physical and digital remittance experience. If fully approved, it would enable Ample Transfers to extend its digital payment solutions to serve its core customer base better while continuing to build on its longstanding community presence. The company's recent launch of remit.ai, an app-less, chat-driven service available at https://www.remit.ai/, complements its established retail footprint—reinforcing its unique approach to accessibility and trust in financial services. "Singapore's payments ecosystem is evolving rapidly, and so are we," said Matthew Yap, CEO of Ample Transfers. "This in-principle approval reflects the growth journey we've shared with the communities we serve. We remain grounded in the needs of everyday people while building for the future with new tools and technologies." Looking ahead, Ample Transfers aims to deepen its commitment to financial inclusion, offering customers even more convenient and secure ways to move money, both online and over the counter. About the IPA from the Monetary Authority of Singapore An in-principle approval (IPA) in respect of a licence variation application reflects MAS's view that the applicant's licence variation application may be approved upon the fulfilment of specified conditions and provided there are no material adverse developments affecting the applicant. An IPA does not constitute an approval for the Company to provide Account Issuance, Domestic Money Transfer, Merchant Acquisition and E-Money Issuance services at this juncture. MAS reserves the right to rescind the IPA in circumstances where it considers appropriate. For media and partnership enquiries: Qing Yuan CHANGHead of Partnerships, Ample Transfersqingyuan@ampletransfers.com
SINGAPORE - Media OutReach Newswire - 11 April 2025 - H&S (the "Company"), a leading Australian wellness company, proudly showcased its exceptional portfolio of brands at FHA-Food & Beverage 2025 ("FHA 2025"), Asia's premier food and hospitality trade show, held from April 8 to 11 in Singapore. H&S leveraged this platform to connect with industry leaders, distributors, and consumers, further solidifying its presence in the global wellness market. H&S’s flagship products exemplify the Company’s state-of-the-art innovations in health and wellness. H&S: A Global Wellness Pioneer Since its establishment in 2009, H&S has emerged as a global pioneer in the wellness industry, delivering premium health solutions to over 50 million consumers across more than 20 countries. At FHA 2025, H&S presented eight flagship brands—Oli6, Brauer, BTNature, Rapid Loss, DOBO, Nutrition29, Moroka, and TEMIO—each representing the Company's commitment to excellence and innovation, making wellness accessible and effortless for individuals worldwide. Innovation in Wellness: Spotlight on Three Flagship Brands BTNature: Science-Backed Dairy Nutrition BTNature has captured attention with its dedication to premium dairy nutrition. Sourcing milk exclusively from Australia and New Zealand, where cows graze on nutrient-rich "Green Gold" ryegrass, BTNature ensures exceptional purity and quality. The brand leverages its patented medium heat powder spraying technology, precisely controlling drying and dusting temperatures. This process preserves the natural nutrients and fresh milk flavor, making BTNature's products highly competitive in global markets. Its standout product, BTNature Premium Full Cream Instant Milk Powder, received the prestigious 3-star award—the highest accolade—at the 2024 Superior Taste Awards and was honored as a Best Dairy Product Finalist at the World Food Innovation Awards 2025. To highlight its versatility, BTNature demonstrated innovative use of its milk powder at FHA 2025—preparing snowflake nougat, inspiring business buyers with creative culinary applications. Brauer: Gentle and Effective Health Solutions With over 90 years of heritage, Brauer has become a trusted brand among Australian families, offering gentle yet highly effective health solutions. Best known for its Kids Vitamins, Brauer integrates natural medicine and potent herbal ingredients to create products loved by parents. Brauer Sambucus Little Sniffles, one of Brauer's signature products, features Sambucus nigra (elderberry), a herb renowned for boosting immunity and alleviating cold and cough symptoms in children as young as six months and older. Its proven effectiveness and widespread acclaim earned it The Consumer Good of the Year (Vitamins & Supplements) award at the FMCG Asia Awards 2024. Mr. Louie Coorey (left), General Manager, Asia Pacific Region at H&S, with Ms. Pragase Komargan (right), Austrade Representative, during FHA 2025 Singapore. Moroka: Immunity Support for All Ages Moroka has positioned itself at the forefront of immunity-boosting nutrition, responding to the growing consumer demand for Lactoferrin-enriched products. Its formulations are packed with essential nutrients such as Immunoglobulin G (IgG), lactoferrin, vitamins, and minerals—designed to support overall immune, respiratory, and digestive health for individuals of all ages. The brand's latest innovation, Moroka Immunity Knight Formulated Milk Powder with Lactoferrin, won the Best Functional Product award at the World Food Innovation Awards 2025. Manufactured in a TGA-certified facility under HACCP and HALAL standards, Moroka continues to deliver scientifically advanced solutions that align with evolving wellness needs. Driving Innovation Through Market Insights H&S's commitment to wellness is deeply rooted in understanding consumer trends. As health-conscious individuals actively seek products that blend efficacy with natural ingredients, the Group has continuously strengthened its research capabilities. By embracing scientifically validated formulations, prioritizing sustainability, and enhancing convenience, H&S ensures its products fulfill the needs of modern consumers. At FHA 2025, H&S engaged attendees with interactive product demonstrations, tastings, and expert discussions, highlighting the unique benefits of its flagship offerings. This milestone event not only amplified H&S's global presence but also set the stage for future collaborations, reinforcing its philosophy that "Happiness Can Be Simple"—making wellness more accessible to all. H&S also delved into strategic discussions with Austrade during the exhibition, focusing on emerging wellness trends and exploring partnership opportunities across Singapore and Southeast Asia. This dialogue underscores H&S's commitment to continuously expanding its regional presence while addressing the ever-evolving demand for integrated health and wellbeing solutions. From left to right: Mr. Louie Coorey, General Manager of the Asia Pacific Region at H&S; Ms. Irene Tay, Business Development Director of Austrade Singapore; Mr. Christopher Morley, Australian Trade and Investment Commissioner; Mr. Jason Zhang, Export Business Development Manager at H&S. H&S staff present the Company’s leading wellness products to business partners at FHA 2025 Singapore. Looking Ahead H&S remains committed to sustainable growth, channelling investments into research and development to expand its premium health and nutrition portfolio. Through a focus on ethical sourcing and cutting-edge innovation, the Company is poised to deliver superior wellness solutions to an even broader audience worldwide. Business Development Contact: Mr. Louie Coorey – General Manager of the Asia-Pacific Region at H&S Mobile: +61401984566 Email: lou.c@hsglobal.com.au Hashtag: #H&S #FHA2025https://hsglobal.com.au/https://www.linkedin.com/company/hs-au/https://www.facebook.com/people/HS/61568352039534/?mibextid=LQQJ4dhttps://www.instagram.com/hsgroup_global/?igsh=MXY0ZWJseDE3eXF2Yg%3D%3DThe issuer is solely responsible for the content of this announcement.About H&SEstablished in Australia, H&S is a globally recognized leader in health and wellness, dedicated to enhancing lives through premium and innovative products. With a presence in over 20 countries, H&S serves more than 50 million consumers worldwide through its network of 300+ international brands, 150+ online stores, and 2,000+ retail locations. Operating across three core sectors—Brands, E-commerce, and Investments—H&S is at the forefront of wellness innovation, driven by a commitment to quality and sustainability. To learn more about H&S and its portfolio, visit hsglobal.com.au.
SINGAPORE - Media OutReach Newswire - 10 April 2025 - Bizcap, an Australia-headquartered leading provider of fast, flexible business loans, has officially launched its Singapore operations. Since entering the market, Bizcap has already funded over $6 million in deals and built strong partnerships with local brokers and advisers, showing early traction and clear demand for fast and flexible funding solutions. With over 100 partners already registered, Bizcap is rapidly building a broker and adviser network to support businesses of all sizes. "Singapore is perfectly positioned as our regional hub for Southeast Asia," said Zalman Blachman, Global Co-Founder of Bizcap. "The SME segment is underserved, and there's strong demand for faster, more accessible funding, similar to what we've seen in Australia, New Zealand, and the UK. The early response from brokers and businesses affirms that SMEs here are actively seeking agile finance partners who understand real-world needs." Bizcap plans to expand into additional Asian markets over the next three years as part of its regional growth strategy. Singapore is Bizcap's fourth active market, following Australia, New Zealand, and the United Kingdom. Bizcap's entry brings a new level of speed and flexibility to local SME finance, with current loan sizes ranging from $5,000 to $500,000, and plans to increase the funding amount over time. The company's flexible risk model goes beyond credit scores, leveraging automated bank statement aggregation and open banking integrations to assess real-world business performance, allowing Bizcap to say yes more often than traditional lenders. As Singapore's financial ecosystem continues to evolve, with open banking frameworks creating new opportunities for smarter, data-driven credit assessment, Bizcap aims to be at the forefront of this innovation, delivering lending decisions that balance agility with a deep understanding of business realities. "Our approach resonates here: simple applications, fast decisions, and meaningful support for brokers and their clients," said Joseph Lim, Asia Managing Partner. During our pre-launch testing, our average assessment time was under four hours. With our new systems coming online, we expect same-day funding to become a reality for eligible Singapore SMEs." Bizcap's partner-first approach is central to its growth, with lifetime commissions, dedicated partner support, and product education all part of its offer. Singapore brokers can choose between two partnership models: Tick and Flick or broker-managed, offering flexibility to suit different customer needs, broker engagement, and commercial models. The Tick and Flick model allows partners to refer clients, with Bizcap handling the full lending process from assessment through to settlement. The company will continue expanding its local presence over the coming months, scaling its Singapore team in line with growth, and introducing more tools and resources for brokers to better serve their clients. Bizcap has also mapped out a product roadmap for Singapore that includes a caveat-secured loan and a revolving line of credit, both set to launch within the next 6 to 12 months. Hashtag: #Bizcaphttps://www.bizcapfunding.sg/https://www.linkedin.com/company/bizcap-singapore/The issuer is solely responsible for the content of this announcement.BizcapBizcap is a leading alternative lender, providing fast, flexible funding to businesses in Singapore, Australia, New Zealand, and the UK. Since its inception in 2019, Bizcap has funded over 30,000 business loans, totaling more than $1 billion, with a 4.8/5 Trustpilot rating. For more information, visit www.bizcapfunding.sg
SINGAPORE, April 10, 2025 /PRNewswire/ -- Singapore business advisory firm VIVOS Pte. Ltd. is pleased to announce the successful completion of the sale and investment in The Providore Singapore Pte. Ltd. The iconic lifestyle F&B brand will now embark on an exciting new chapter under the leadership of experienced industry professionals through Vino Vibe Pte. Ltd. and SingFire Capital Pte. Ltd. This transaction marks the strategic exit of founder Robert Collick, who built The Providore into one of Singapore's most beloved lifestyle F&B brands. VIVOS Advises on Sale of The Providore Singapore to F&B Industry Veterans The new ownership team — long-time admirers of The Providore — plans to build on its strong foundation and further invest in its continued growth in Singapore and beyond. Their vision is to evolve the brand by introducing new concepts and experiences, while preserving the café, bakery, deli, and retail elements that customers have come to know and love. Following this transition, Mr. Robert Collick will step back from day-to-day operations to spend more time with his family and pursue broader business interests. Commenting on the transaction, Mr. Collick said, "The Providore has always been a cherished part of Singapore's F&B scene. With this new investment, I believe Vino Vibe and SingFire Capital will take the brand to greater heights. I look forward to seeing what's next for The Providore." Ms. Tang Ming, representing SingFire Capital, shared, "I've been a devoted fan of The Providore for years. It's more than just a café – it's a lifestyle experience. We're thrilled to be part of this exciting new chapter and look forward to bringing even more fresh and inspiring offerings to our customers." The new owners stated that their goal is to stay true to the brand's core values while evolving The Providore into a space that embodies 'Quality Living × Borderless Socializing.' By merging The Providore's artisanal food heritage with BlacBlac's wine culture, the vision is to create a hybrid lifestyle destination that celebrates high-quality ingredients in a relaxed social setting — connecting Asia with global culinary inspiration through food and wine, and empowering sustainable urban living. Mr. Tang Yun Hai, Director of Vino Vibe, further added: "We will continue The Providore's uncompromising standards by curating premium organic ingredients and fine wines. By day, the space will operate as a brunch venue; by night, it will transform into a relaxed wine bar. Through this shift in ambiance, we aim to serve a diverse audience — from white-collar afternoon tea seekers to night-time socialites — redefining the 'free boundaries' of city dining and offering a stylish yet unhurried third space for the new generation." The transaction was arranged and advised by VIVOS Pte Ltd., who acted as the exclusive advisor to Mr. Collick throughout the process. Commenting on the deal, Mr. Ray Tay, Director at VIVOS, said: "It's been a privilege to advise on this transaction and help facilitate a seamless handover between such seasoned F&B players. We're confident The Providore is in great hands for its next phase of growth." About The Providore Founded in Singapore, The Providore has grown to become a beloved destination for food lovers, offering a unique combination of cafés, bakeries, delis, and premium grocery retail. More about The Providore: https://theprovidore.com/ About VIVOS Leading Business Consulting Firm VIVOS is a trusted name in the corporate services, business advisory and immigration industry. With over 1000+ satisfied clients, VIVOS has positioned itself as a top choice for foreign investors, entrepreneurs and businesses looking to establish and scale their presence in Singapore. Our website https://VIVOS.com.sg/ For media enquiries, please contact: hello@theprovidore.com
新加坡2025年4月9日 /美通社/ -- 位於新加坡濱海灣核心地帶及中央商務區繁華中心的新加坡泛太平洋酒店(Pan Pacific Singapore)，是精緻優雅與卓越待客理念的典範。作為會議，獎勵，會展與展覽(MICE)的理想之選，酒店配備一系列專為高端商務旅客量身打造的設施和服務。 新加坡泛太平洋酒店 新加坡泛太平洋酒店(Pan Pacific Singapore)總經理林文彬表示：「自1986年開業以來，我們便是濱海灣地區首批奢華酒店之一，書寫了輝煌歷史。酒店擁有790間設計典雅的客房，深受國際領導企業及大型活動主辦方的青睞。我們對卓越品質的不懈追求，體現在面積達2329平方米、橫跨三層的會議空間上——所有場地均配備尖端視聽設備，並提供創新餐飲體驗。」 賓客可以在屢獲殊榮的聖葛儷水療中心(St. Gregory)放鬆休憩，或在戶外泳池悠然暢遊。24小時健身中心則為賓客日常鍛煉提供了靈活選擇。美食愛好者在此可盡享多樣餐飲體驗：在PLUME酒吧品嚐特色雞尾酒和精緻小食，在海天樓(Hai Tien Lo)中餐廳享用正宗粵菜，在Keyaki日式餐廳體驗傳統日本料理，亦可在Edge和Pacific Emporium餐廳品味國際佳餚。 為慶祝新加坡建國60週年(SG60)，酒店特推出融合新加坡特色的SG60 MICE套餐，有效期至2026年3月31日。每場茶歇皆是一場感官盛宴，提供豐富多樣的新加坡特色美食。在廚師現場烹飪台，賓客可品嚐即時烹製的當地佳餚，如咖椰吐司（新加坡標誌性早餐，由兩片塗有濃郁椰漿果醬和黃油的烤吐司組成）、新鮮薄餅（新加坡街頭美食文化的一部分，源自中國，鬆軟的春卷內裹有鮮蝦、雞蛋和脆爽蔬菜等餡料）、娘惹糕（色彩繽紛的傳統小吃，展現新加坡土生華人文化，以米粉製成，內填甜鹹餡料）、拉咖啡（源自馬來西亞，馬來語為「Kopi Tarik」，一種以咖啡和煉乳調製的大眾飲品，經獨特「拉」制手法，呈現綿密奶泡口感）等。這些地道美食不僅提升了與會者的會議體驗，更彰顯了新加坡泛太平洋酒店對慶祝新加坡建國60週年的誠摯心意。 全天會議套餐每位賓客155新元起，含午餐和兩次茶歇。若議程較短，還可選擇半天會議套餐，每位賓客140新元起，含午餐和一次茶歇。更多詳情，請點擊此處。 新加坡泛太平洋酒店(Pan Pacific Singapore)秉承卓越接待傳統，是追求面對面交流效果的賓客的首選之地。在這裡，精彩活動將優雅與創新完美融合，打造出難忘的體驗。 此外，酒店還致力於可持續發展，榮獲全球可持續旅遊委員會(GSTC)認證、ISO 14001環境管理體系認證 、ISO 45001職業健康安全管理體系認證 ，以及新加坡建設局(BCA)綠色建築標誌金獎 。這些確保在此舉辦的會議和活動，既符合最高標準，又踐行了安全與環保理念。 欲瞭解更多信息，請訪問www.panpacific.com/en/hotels-and-resorts/pp-marina/meetings.html或發送電郵至sales.ppsin@panpacific.com（請註明SG60）。 新加坡泛太平洋酒店——雅致與奢華在這裡邂逅，重新詮釋會議藝術典範。 點擊此處查看我們的MICE圖片。欲瞭解有關新加坡泛太平洋酒店的更多信息，請點擊這裡。
Five-year strategic partnership to improve patient care Focus on developing new technologies, improving diagnostics and treatment protocols, providing training and knowledge sharing. SINGAPORE, April 8, 2025 /PRNewswire/ -- Siemens Healthineers and Singapore General Hospital (SGH) have recently signed a Memorandum of Understanding (MOU) to establish a five-year strategic partnership to advance healthcare solutions and support SGH in medical innovation. Working together, the two organizations aim to strengthen Singapore's healthcare ecosystem by driving continuous learning, innovation, and excellence in patient care. A/Prof Andrew Tan of SGH, Dr Jochen Schimtz of Siemens Healthineers, A/Prof Ruban Poopalalingam of SGH, and Enno Nehrbass of Siemens Healthineers signed the MOU pledge in Siemens Healthineers HQ Erlangen, Germany. The MOU, signed at the Siemens Healthineers headquarters in Erlangen, Germany, focuses on improving patient care by developing new technologies, clinical solutions, and data-driven approaches to enhance diagnostics and treatment protocols. The collaboration emphasizes hands-on training, workshops, and knowledge-sharing initiatives to build expertise and capacity, while also laying the foundation for future advancements in AI-driven diagnostics, digital health solutions, and sustainability initiatives. "Singapore General Hospital has always been our valued partner in diagnostic imaging, and this partnership marks a significant step forward in driving medical innovation and enhancing patient outcomes," said Ms Siow Ai Li, Managing Director, Siemens Healthineers Singapore and Malaysia. "Collaboration is key to advancing healthcare. By co-developing new clinical solutions and leveraging our expertise, we are committed to supporting SGH and the broader Singapore healthcare landscape in pioneering future-ready innovations." This strategic partnership is built on these key pillars: Clinical Research and Collaboration – Siemens Healthineers and SGH aim to develop new technologies, clinical solutions and data-driven approaches to enhance diagnostic and treatment capabilities and protocols. This collaboration aims to foster innovation and improve patient care through joint research initiatives and clinical trials. Education and Training - Siemens Healthineers is committed to supporting SGH with the latest knowledge and skills. Through partnering with SGH for hands-on training, workshops, and knowledge-sharing initiatives, this partnership will build expertise and capacity to deliver better patient care. Future-ready Healthcare: The partnership will lay the foundation for future collaboration in areas such as AI-driven diagnostics, digital health solutions, and sustainability initiatives. By leveraging advanced technologies, SGH and Siemens Healthineers aim to stay at the forefront of medical innovation. This collaboration creates valuable opportunities for mutual knowledge exchange between Siemens Healthineers and SGH. By sharing best practices and expertise, both parties can co-develop innovative solutions that address evolving healthcare challenges. Siemens Healthiners aims to support SGH's medical professionals with our innovative services and insights, while SGH's clinical expertise and real-world experience will help refine and advance cutting-edge medical technologies. "This partnership marks another step towards future-ready healthcare, opening up exciting possibilities in diagnostic imaging and radiological sciences. We look forward to working closely with Siemens Healthineers to pioneer new approaches in diagnostics and treatment, driven by AI and data, while building valuable expertise among our healthcare professionals through knowledge exchange and training initiatives," said Associate Professor Andrew Tan, Chairman, Division of Radiological Sciences, SGH. "At Siemens Healthineers, we are convinced that strategic partnerships are pivotal to advancing healthcare for everyone," said Dr Jochen Schmitz, CFO Siemens Healthineers. "It was a pleasure to recently welcome the team from Singapore General Hospital in Erlangen and engage in a meaningful exchange of ideas on co-developing solutions that benefit both patients and healthcare professionals. We look forward to continuing our collaboration based on the pillars of this memorandum of understanding." The two organizations aim to determine the next areas of focus for various workstreams, with a steering committee set to oversee and guide activities under this strategic partnership and MOU. This press release and a press picture is available at https://www.siemens-healthineers.com/en-sg/press-room/press-releases-sg/sgh-signs-mou-with-shs-5-years-strategic-partnership The product/features mentioned in this press release is/are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details. The product and features mentioned in this press release are meant for healthcare professionals only. Contact for media enquiries, please get in touch with: Siemens HealthineersJo'an ChngHead of Marketing, Sales Operations and CommunicationsPhone: +65 8328 1015; E-mail: jo-an.chng@siemens-healthineers.com Singapore General HospitalCandice LeeCommunications, Singapore General HospitalEmail: candice.lee.l.f@sgh.com.sg Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com. Singapore General Hospital, established in 1821, is the largest acute tertiary hospital in Singapore and ranked among the world's best. It provides the most comprehensive patient-centred care with over 50 clinical specialties on its campus. As an Academic Medical Centre, it takes pride in training healthcare professionals and conducting cutting edge research to meet evolving needs of the nation as well as the region. Driven by a strong sense of purpose, SGH is committed to give of its best to heal and bring hope, as it has for over 200 years. Clinical research is an integral part of SGH's institutional practice and is actively carried out by clinicians and scientists from medical, nursing and allied health departments. The hospital leverages on its multi-disciplinary capabilities, depth of specialization, a large patient base and its research affiliations with renowned centres locally and globally. A not-for-profit institution, SGH is wholly owned by the government of Singapore and the flagship hospital of the public healthcare system. SGH is a member of the SingHealth cluster of healthcare institutions. Further information is available at www.sgh.com.sg.
Singapore
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
